$458 Million is the total value of Stanley-Laman Group, Ltd.'s 215 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2013 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-03-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 40 | Q3 2023 | 1.4% |
| ABBVIE INC | 40 | Q3 2023 | 4.2% |
| C V S HEALTH CORPORATION | 39 | Q3 2023 | 0.9% |
| UNITEDHEALTH GRP INC | 38 | Q3 2023 | 0.9% |
| EAGLE PHARMACEUTICALS | 37 | Q3 2023 | 0.7% |
| MICROSOFT CORP | 36 | Q3 2023 | 2.1% |
| BOEING CO | 36 | Q3 2023 | 1.0% |
| HONEYWELL INTL INC TRADES WITH DUE BILLS | 34 | Q3 2023 | 0.8% |
| LYONDELLBASELL INDS F DUTCH TENDER EXP: 07/08/19 | 34 | Q3 2023 | 0.6% |
| JOHNSON & JOHNSON | 34 | Q3 2023 | 0.5% |
View Stanley-Laman Group, Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-17 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-10-16 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-04-18 |
| 13F-HR | 2023-01-19 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-04-21 |
| 13F-HR | 2022-01-25 |
View Stanley-Laman Group, Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.